The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes
Open accessAbstract
Tumor suppressor genes (TSGs) are a major type of gatekeeper genes in the cell growth. A knowledgebase with the systematic collection and curation of TSGs in multiple cancer types is critically important for further studying their biological functions as well as for developing therapeutic strategies. Since its development in 2012, the Tumor Suppressor Gene database (TSGene), has become a popular resource in the cancer research community. Here, we reported the TSGene version 2.0, which has substantial updates of contents (e.g. up-to-date literature and pan-cancer genomic data collection and curation), data types (noncoding RNAs and protein-coding genes) and content accessibility. Specifically, the current TSGene 2.0 contains 1217 human TSGs (1018 protein-coding and 199 non-coding genes) curated from over 9000 articles. Additionally, TSGene 2.0 provides thousands of expression and mutation patterns derived from pan-cancer data of The Cancer Genome Atlas. A new web interface is available at http://bioinfo.mc.vanderbilt.edu/TSGene/. Systematic analyses of 199 non-coding TSGs provide numerous cancer-specific non-coding mutational events for further screening and clinical use. Intriguingly, we identified 49 protein-coding TSGs that were consistently down-regulated in 11 cancer types. In summary, TSGene 2.0, which is the only available database for TSGs, provides the most updated TSGs and their features in pan-cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Chen, J., Bardes, E. E., Aronow, B. J., & Jegga, A. G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp427 · Cited by 2,952
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
The Emergence of lncRNAs in Cancer Biology
Prensner, J. R., & Chinnaiyan, A. M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0209 · Cited by 1,770
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
Vlachos, I. S., Zagganas, K., Paraskevopoulou, M. D., Georgakilas, G., Karagkouni, D., Vergoulis, T., Dalamagas, T., & Hatzigeorgiou, A. G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv403 · Cited by 1,699
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Pathway Commons, a web resource for biological pathway data
Cerami, E. G., Gross, B. E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G. D., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1039 · Cited by 1,101 · cited 1×
“It is supported by integrated high-throughput experiments, metabolic and signaling interactions, and helps users explore partners interacting with each TSG (34).”
BackgroundPrinciples of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.029 · Cited by 1,019
Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F., & Williams, G. T. (2009) · Oncogene · doi:10.1038/onc.2008.373 · Cited by 775
MicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
Kent, O. A., & Mendell, J. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209913 · Cited by 720
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Crystal, A. S., Shaw, A. T., Sequist, L. V., Friboulet, L., Niederst, M. J., Lockerman, E. L., Frias, R. L., Gainor, J. F., Amzallag, A., Greninger, P., et al. (2014) · Science · doi:10.1126/science.1254721 · Cited by 708
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677
Tumour-suppressor activity of H19 RNA
Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., & Tycko, B. (1993) · Nature · doi:10.1038/365764a0 · Cited by 630
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice
Yildirim, E., Kirby, J. E., Brown, D. E., Mercier, F. E., Sadreyev, R. I., Scadden, D. T., & Lee, J. T. (2013) · Cell · doi:10.1016/j.cell.2013.01.034 · Cited by 522
A tumor suppressor and oncogene: the WT1 story
Yang, L., Han, Y., Saurez Saiz, F., & Minden, M. D. (2007) · Leukemia · doi:10.1038/sj.leu.2404624 · Cited by 471
The landscape and therapeutic relevance of cancer-associated transcript fusions
Yoshihara, K., Wang, Q., Torres-Garcia, W., Zheng, S., Vegesna, R., Kim, H., & Verhaak, R. G. W. (2015) · Oncogene · doi:10.1038/onc.2014.406 · Cited by 450
HIV-1 Integration Landscape during Latent and Active Infection
Cohn, L. B., Silva, I. T., Oliveira, T. Y., Rosales, R. A., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J. L., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 444
MicroRNAs and their target gene networks in breast cancer
O'Day, E., & Lal, A. (2010) · Breast Cancer Research · doi:10.1186/bcr2484 · Cited by 439
Database resources of the National Center for Biotechnology Information
Coordinators, N. R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1130 · Cited by 397
LncRNA loc285194 is a p53-regulated tumor suppressor
Liu, Q., Huang, J., Zhou, N., Zhang, Z., Zhang, A., Lu, Z., Wu, F., & Mo, Y.-Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt182 · Cited by 384
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
Lobry, C., Oh, P., & Aifantis, I. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111855 · Cited by 356
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer
Askarian-Amiri, M. E., Crawford, J., French, J. D., Smart, C. E., Smith, M. A., Clark, M. B., Ru, K., Mercer, T. R., Thompson, E. R., Lakhani, S. R., et al. (2011) · RNA · doi:10.1261/rna.2528811 · Cited by 334
TSGene: a web resource for tumor suppressor genes
Zhao, M., Sun, J., & Zhao, Z. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks937 · Cited by 330
Self-citationPintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2
Marín-Béjar, O., Marchese, F. P., Athie, A., Sánchez, Y., González, J., Segura, V., Huang, L., Moreno, I., Navarro, A., Monzó, M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r104 · Cited by 265
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
Mavrakis, K. J., Van Der Meulen, J., Wolfe, A. L., Liu, X., Mets, E., Taghon, T., Khan, A. A., Setty, M., Rondou, P., Vandenberghe, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.858 · Cited by 261
Liu, Y., Corcoran, M., Rasool, O., Ivanova, G., Ibbotson, R., Grandér, D., Iyengar, A., Baranova, A., Kashuba, V., Merup, M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201643 · Cited by 215
Chen, C.-L., Tseng, Y.-W., Wu, J.-C., Chen, G.-Y., Lin, K.-C., Hwang, S.-M., & Hu, Y.-C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.023 · Cited by 214
Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21
Wang, P., Liu, Y.-H., Yao, Y.-L., Li, Z., Li, Z.-Q., Ma, J., & Xue, Y.-X. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.011 · Cited by 210
Haber, D. A., & Settleman, J. (2007) · Nature · doi:10.1038/446145a · Cited by 203
Wang, D., Qiu, C., Zhang, H., Wang, J., Cui, Q., & Yin, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013067 · Cited by 197
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
Yu, J., Wu, W. K. K., Li, X., He, J., Li, X.-X., Ng, S. S. M., Yu, C., Gao, Z., Yang, J., Li, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-306620 · Cited by 188
Pasic, I., Shlien, A., Durbin, A. D., Stavropoulos, D. J., Baskin, B., Ray, P. N., Novokmet, A., & Malkin, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1902 · Cited by 171
Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes
Blattler, A., Yao, L., Witt, H., Guo, Y., Nicolet, C. M., Berman, B. P., & Farnham, P. J. (2014) · Genome Biology · doi:10.1186/preaccept-3878619451311053 · Cited by 162
MicroRNAs as tumor suppressors
Hammond, S. M. (2007) · Nature Genetics · doi:10.1038/ng0507-582 · Cited by 158
A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells
FAN, M., Li, X., Jiang, W. H., Huang, Y., Li, J., & Wang, Z. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.933 · Cited by 157
Bullrich, F., Fujii, H., Calin, G. A., Mabuchi, H., Negrini, M., Pekarsky, Y., Rassenti, L. Z., Alder, H., Reed, J. C., Keating, M. J., et al. (2001) · Cancer Research · Cited by 153
Xia, T., Chen, S., Jiang, Z., Shao, Y., Jiang, X., Li, P., Xiao, B., & Guo, J. (2015) · Scientific Reports · doi:10.1038/srep13445 · Cited by 153
Yao, J., Zhou, B., Zhang, J., Geng, P., Liu, K., Zhu, Y., & Zhu, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-1949-2 · Cited by 132
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Santoro, F., Botrugno, O. A., Zuffo, R. D., Pallavicini, I., Matthews, G. M., Cluse, L. A., Barozzi, I., Senese, S., Fornasari, L., Moretti, S., et al. (2013) · Blood · doi:10.1182/blood-2012-10-461988 · Cited by 132
Gong, Z., Zhang, S., Zeng, Z., Wu, H., Yang, Q., Xiong, F., Shi, L., Yang, J., Zhang, W., Zhou, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110674 · Cited by 112
Yu, W., Qiao, Y., Tang, X., Ma, L., Wang, Y., Zhang, X., Weng, W., Pan, Q., Yu, Y., Sun, F., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.011 · Cited by 107
GeneRIF QUALITY ASSURANCE AS SUMMARY REVISION
Lu, Z., Cohen, K. B., & Hunter, L. (2006) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789812772435_0026 · Cited by 102
AlQuraishi, M., Koytiger, G., Jenney, A., MacBeath, G., & Sorger, P. K. (2014) · Nature Genetics · doi:10.1038/ng.3138 · Cited by 63
MeT-DB: a database of transcriptome methylation in mammalian cells
Liu, H., Flores, M. A., Meng, J., Zhang, L., Zhao, X., Rao, M. K., Chen, Y., & Huang, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1024 · Cited by 63
Human miR-31 targets radixin and inhibits migration and invasion of glioma cells
Lin, B. (2011) · Oncology Reports · doi:10.3892/or.2011.1555 · Cited by 57
From oncogene to tumor suppressor: The dual role of Myc in leukemia
Uribesalgo, I., Benitah, S. A., & Croce, L. D. (2012) · Cell Cycle · doi:10.4161/cc.19883 · Cited by 52
Zhao, M., Sun, J., & Zhao, Z. (2013) · Molecular BioSystems · doi:10.1039/c3mb70172g · Cited by 42
Self-citationDual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung.
Pelosi, G., Fumagalli, C., Trubia, M., Sonzogni, A., Rekhtman, N., Maisonneuve, P., Galetta, D., Spaggiari, L., Veronesi, G., Scarpa, A., et al. (2010) · PubMed · Cited by 40
CNVannotator: A Comprehensive Annotation Server for Copy Number Variation in the Human Genome
Zhao, M., & Zhao, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080170 · Cited by 37
Self-citationZhao, M., Sun, J., & Zhao, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044175 · Cited by 34
Self-citationOncogene and tumour suppressor: the two faces of SnoN
Lamouille, S., & Derynck, R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.311 · Cited by 22
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus
Vitale, N., Horiba, K., Ferrans, V. J., Moss, J., & Vaughan, M. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8613 · Cited by 22
Zhao, M., Li, Z., & Qu, H. (2015) · Scientific Reports · doi:10.1038/srep15478 · Cited by 19
Self-citation
Cited by
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
G-quadruplex structures mark human regulatory chromatin
Hänsel-Hertsch, R., Beraldi, D., Lensing, S. V., Marsico, G., Zyner, K., Parry, A., Di Antonio, M., Pike, J., Kimura, H., Narita, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3662 · Cited by 964
Repana, D., Nulsen, J., Dressler, L., Bortolomeazzi, M., Venkata, S. K., Tourna, A., Yakovleva, A., Palmieri, T., & Ciccarelli, F. D. (2019) · Genome Biology · doi:10.1186/s13059-018-1612-0 · Cited by 674
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
Brocks, D., Schmidt, C. R., Daskalakis, M., Jang, H. S., Shah, N. M., Li, D., Li, J., Zhang, B., Hou, Y., Laudato, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3889 · Cited by 339
N-methyladenine DNA Modification in Glioblastoma
Xie, Q., Wu, T. P., Gimple, R. C., Li, Z., Prager, B. C., Wu, Q., Yu, Y., Wang, P., Wang, Y., Gorkin, D. U., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.006 · Cited by 325
Metadata
- Authors
- Zhao, M., Kim, P., Mitra, R., Zhao, J., & Zhao, Z.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-20
- Volume
- 44
- Issue
- D1
- Pages
- D1023-D1031
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2177605184
- Cited by
- 399
- References
- 64
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.